Results 21 to 30 of about 10,175 (227)

Fludrocortisone to treat patients with aneurysmal subarachnoid haemorrhage: Protocol for an international, phase 3, randomised, placebo-controlled, multicentre trial. [PDF]

open access: hybridCrit Care Resusc
Cohen J   +25 more
europepmc   +2 more sources

Management of Primary Adrenal Insufficiency and Overt Hypothyroidism in an HIV-Positive Patient in a Resource-Limited Setting: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT In resource‐limited settings, clinicians must maintain a high index of suspicion for primary adrenal insufficiency and hypothyroidism in HIV‐positive patients presenting with non‐specific symptoms. Relying on clinical judgment and response to treatment is crucial when confirmatory tests are unavailable.
Edward M, John W, Raphael DM.
europepmc   +2 more sources

Management of Addison's disease in dogs [PDF]

open access: yes, 2016
No abstract ...
Ramsey, Ian   +2 more
core   +1 more source

Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean Region: it takes a village…

open access: yesBMJ Global Health, 2021
Congenital adrenal hyperplasia (CAH), if untreated, carries high morbidity and mortality. A higher incidence of CAH is expected in countries where consanguinity is common, such as in the countries of the WHO Eastern Mediterranean Region (EMRO).
  +32 more
doaj   +1 more source

Growth Patterns in the First Three Years of Life in Children with Classical Congenital Adrenal Hyperplasia Diagnosed by Newborn Screening and Treated with Low Doses of Hydrocortisone [PDF]

open access: yes, 2011
Background: Linear growth is the best clinical parameter for monitoring metabolic control in classical congenital adrenal hyperplasia (CAH). Objective: To analyze growth patterns in children with CAH diagnosed by newborn screening and treated with ...
Bonfig, W., Schmidt, H., Schwarz, H. P.
core   +1 more source

Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background A single dose of small interfering RNA (siRNA) targeting liver angiotensinogen eliminates hepatic angiotensinogen and lowers blood pressure.
Estrellita Uijl   +11 more
doaj   +1 more source

Diagnosis and treatment of canine hypoadrenocorticism [PDF]

open access: yes, 2018
Canine hypoadrenocorticism (Addison’s disease), the ‘great pretender’ of internal medicine, is a disease that should be frequently considered as a differential diagnosis of several clinical presentations, albeit it is less commonly the actual cause of ...
Gunn, Eilidh   +2 more
core   +1 more source

The Inositol- 1,4,5=Trisphosphate System Is Involved in Rapid Effects of Aldosterone in Human Mononuclear Leukocytes [PDF]

open access: yes, 1993
There is increasing evidence for rapid steroid action on electrolyte transport in human mononuclear leukocytes (HML). In HML, aldosterone stimulates the Na+/H+ antiporter within a few minutes. Because a variety of hormones and growth factors activate the
Aktas, Janet   +4 more
core   +1 more source

Use of fludrocortisone for intradialytic hypotension

open access: yesKidney Research and Clinical Practice, 2018
Intradialytic hypotension during dialysis adversely affects a patient's prognosis and increases mortality. We report a case in which intradialytic hypotension that persisted after the administration of midodrine was relieved after the use of ...
Yuri Seo   +5 more
doaj   +1 more source

Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia [PDF]

open access: yes, 2006
Objective: Familial glucocorticoid deficiency type I (FGD1) is a rare form of primary adrenal insufficiency resulting from recessive mutations in the ACTH receptor (MC2R, MC2R).
Achermann, JC   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy